Form 4: Elevance Health Director Receives Stock Grant

Director Deanna D. Strable-Soethout acquired 563 deferred stock units as part of the Elevance Health Board of Directors Compensation Program.

Summary

• Director Deanna D. Strable-Soethout was granted 563 deferred stock units on May 13, 2026.
• The grant was issued under the Elevance Health, Inc. Board of Directors Compensation Program.
• Following this transaction, the director's total beneficial ownership of common stock is 2,209 shares.
• The units are payable in common stock upon the earlier of five years from the grant date or the director's departure from the board.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Director compensation via equity aligns the interests of board members with those of shareholders.

Negatives

• None identified.

Risks

• The value of the deferred stock units is subject to the future market performance of Elevance Health common stock.

Future Outlook

The deferred stock units are scheduled to vest and be payable in common stock in five years or upon the director's separation from the board, whichever occurs first.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the healthcare insurance sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The use of deferred stock units for director compensation is consistent with standard practices among large-cap healthcare companies like UnitedHealth Group and Cigna.

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard board compensation practices.

Next Steps

• The director will hold the deferred stock units until the specified vesting conditions are met.

Key Dates

Keywords

Elevance Health, ELV, Form 4, Director Compensation, Insider Transaction, Deferred Stock Units